Genome Insight Institute

Inocras (formerly Genome Insight) is a bioinformatics-led precision medicine company specializing in whole genome sequencing (WGS) and AI-driven analytics. Founded in 2020 by a team of physician-scientists and bioinformaticians, the company aims to transform patient care by unlocking the full potential of genomic data for cancer and rare diseases. Their proprietary platform, which includes products like CancerVision and RareVision, provides clinicians and researchers with comprehensive, actionable insights at a fraction of the traditional cost and time. Headquartered in San Diego, Inocras operates a CLIA-certified and CAP-accredited laboratory and maintains a significant research presence through the Genome Insight Institute in South Korea. The company collaborates with global leaders like the Broad Institute and KAIST to advance the field of precision oncology and drug discovery.